Hologic Completes Cash Tender Offer for Third Wave Technolo...(who did nottender their shares in Third ...)

Date:7/24/2008

who did not tender their shares in Third Wave in the offer outlining the steps to be taken to obtain the merger consideration. The effective date of the merger is anticipated to be July 24, 2008 and after the close of business on the effective date, trading in Third Wave common stock on the NASDAQ will cease.

About Hologic, Inc.

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic's core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health. Hologic provides a comprehensive suite of technologies with products for mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia, osteoporosis assessment, preterm birth risk assessment, and mini C-arm for extremity imaging. For more information visit http://www.hologic.com.

About Third Wave, Inc.

Third Wave develops and markets molecular diagnostic reagents for a variety of DNA and RNA analysis applications to meet the needs of its customers. Third Wave offers a number of products based on its Invader(R) chemistry for clinical testing. Third Wave offers in vitro diagnostic kits, and analyte specific, general purpose, and research use only reagents for nucleic acid analysis. For more information about Third Wave and its products, please visit Third Wave's website at http://www.twt.com.

Information Concerning Forward-Looking Statements

Information set forth in this communication contains forward-looking statements, which involve a number of risks and uncertainties. Such forward-looking statements include, but are not limited to Hologic's plans, objectives, expectations and intentions and other statements that are not historical facts. Holog
'/>"/>

SOURCE Hologic, Inc. Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related biology technology :

1. Hologic, Inc. to Release First Quarter Fiscal 2008 Operating Results Thursday, January 31st Before Market Opens
2. Hologic to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
3. Hologic Announces First Quarter Fiscal 2008 Operating Results
4. Hologic to Present at the Sun Trust Robinson Humphreys 37th Annual Institutional Conference
5. Hologic, Inc. to Release Second Quarter Fiscal 2008 Operating Results Thursday, May 1st Before Market Opens
6. Hologic to Present at the Bank of America Healthcare Conference
7. Hologic to Present at the Citigroup Investment Research Global Healthcare Conference
8. Hologic to Present at the Needham Seventh Annual Biotechnology and Medical Technology Conference
9. Hologic, Inc. Accepts Shares of Third Wave Technologies, Inc. in Tender Offer and Commences Subsequent Offering Period
10. H2Diesel Completes 3 Million Gallon Per Year Pilot Facility
11. AEterna Zentaris completes management team with the appointment of Chief Medical Officer